US 9364535
Methods and compositions for modulating lymphangiogenesis, e.g., to treat transplant rejection, in a subject
granted A61KA61K2039/507A61K35/30
Quick answer
US patent 9364535 (Methods and compositions for modulating lymphangiogenesis, e.g., to treat transplant rejection, in a subject) held by The Regents of the University of California expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/507, A61K35/30, A61K39/3955